Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Conditions
- Breast Adenocarcinoma
- Breast Cancer Stage IV
- Breast Cancer, Metastatic
- Breast Carcinoma
- Breast Diseases
- Breast Neoplasms
- Breast Neoplasms, Male
- Breast Cancer
- Breast Cancer With Metastatic Bone Disease
- Breast Cancers
- Breast Neoplasm
- Breast Tumors
- HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
- HR+ Advanced or Metastatic Breast Cancer
- HR+/HER2- Breast Cancer
- HRpos Breast Neoplasms
- HR-positive, HER2-negative Advanced Breast Cancer
- HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
- HR-positive Breast Cancer
- Hormone Receptor-Positive Breast Cancer
- Hormone Receptor Positive Breast Adenocarcinoma
- Hormone Receptor Positive Breast Carcinoma
- Hormone Receptor Positive Breast Neoplasms
- Hormone Receptor Positive HER-2 Negative Breast Cancer
- Hormone Receptor Positive Malignant Neoplasm of Breast
- Hormone Receptor Positive Metastatic Breast Cancer
- Hormone Receptor Positive, HER2 Negative Breast Cancer
- Hormone Receptor Negative Breast Cancer
- Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
- Hormone Receptor Positive Breast Cancer
- Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer
- Hormone Receptor Positive, HER2-negative Neoplasms
- Hormone Receptor Positive, HER2-low Neoplasms
- Hormone Receptor Positive (HR+), HER2-negative Breast Cancer
- Hormone Receptor (HR)-Positive Breast Cancer
- Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
- Palbociclib
- Ribociclib
- Abemaciclib
- CDK4/6 Inhibitor
- CDK4/6 Inhibitors
Interventions
- DRUG: Palbociclib
- DRUG: Ribociclib
- DRUG: Abemaciclib
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]